Health Committee ought to put Canadians’ needs first, not big pharma
Dec. 13, 2017
The pharmaceutical industry clearly has a vested interest in the details of a pharmacare plan, now under consideration by the House Health Committee. So do Canadians whose health depends on prescription drugs. But are their interests the same?
People. Policy. Politics. This is an exclusive subscriber-only story.
David MacNaughton 'made it a priority' to understand who the key U.S. influencers were and which Canadian would be best to deliver the message, says former PMO Canada-U.S. war room staffer Diamond Isinger.